| 3531 |
National Institute of Arthritis and Musculoskeletal and Skin Diseases |
Html |
en |
La historia de Isabel: Cómo ella y su familia aprendieron sobre la osteoporosis y la salud de los huesos. |
Esta es la historia de Isabel y cómo ella y su familia aprendieron acerca del la osteoporosis y la salud ósea. |
| risk factors | 0.63815 |
| treatable disease | 0.83909 |
| bones | 0.300041 |
| bone fracture | 0.920631 |
|
| Americans | 0.301625 |
| Learn | 0.203005 |
| osteoporosis | 0.578039 |
|
CLICK HERE |
| 3545 |
National Institute of Arthritis and Musculoskeletal and Skin Diseases |
Html |
es |
¿Qué es el acné? (Esenciales: hojas informativas de fácil lectura) |
El acné es una enfermedad que afecta las glándulas sebáceas. El acné es la enfermedad de la piel más común. Las personas de todas las razas y de todas las edades pueden tener acné. |
| Health Statistics | 0.387369 |
| glándulas sebáceas | 0.945868 |
| datos abiertos lista | 0.460697 |
| Disease Control | 0.377137 |
| Centro Nacional | 0.361634 |
| adultos jóvenes | 0.820766 |
|
| sustancia grasosa llamada | 0.704803 |
| privacidad acceso | 0.351992 |
| NIAMS FOIA Aviso | 0.545075 |
| pequeños orificios | 0.468319 |
| vÃa oral | 0.424285 |
|
CLICK HERE |
| 3546 |
National Institute of Arthritis and Musculoskeletal and Skin Diseases |
Html |
es |
¿Qué es la fibromialgia? (Esenciales: hojas informativas de fácil lectura) |
La fibromialgia es un trastorno que causa dolores musculares y fatiga (cansancio). Las personas con fibromialgia tienen “puntos hipersensibles” en el cuerpo. Las personas que padecen de fibromialgia pueden también tener otros síntomas. |
| datos abiertos lista | 0.684212 |
| Mala memoria | 0.712723 |
| Centro Nacional | 0.614702 |
| principales sÃntomas | 0.701501 |
| NIAMS FOIA Aviso | 0.730336 |
| actividades relajantes | 0.635234 |
| Enter email address | 0.717473 |
|
| larga duración | 0.958254 |
| sueño reparador | 0.714685 |
| fuerte reacción | 0.713228 |
| siguientes acontecimientos | 0.706276 |
| siguientes medicamentos | 0.695912 |
| privacidad acceso | 0.606511 |
|
CLICK HERE |
| 15538 |
National Institute of Allergy and Infectious Diseases |
Html |
en |
NIAID's Programs on Asthma in the Inner City |
Recognizing that asthma severity in inner-city children is disproportionately high, NIAID has sponsored research to reduce the public health burden that asthma presents in inner-city populations. Beginning in 1991, NIAID has supported three consecutive inner-city asthma research programs, which have been successful in reducing asthma severity in children. |
| inner-city populations | 0.579525 |
| Morgan WJ | 0.496915 |
| cockroach allergen | 0.471241 |
| inner-city children. | 0.516784 |
| asthma severity | 0.746089 |
| inner-city adolescents | 0.569622 |
| environmental intervention study | 0.506189 |
| clinical trials | 0.457073 |
| Infectious Diseases networks | 0.482159 |
| asthma exacerbations | 0.604543 |
| asthma attacks | 0.618501 |
| Gergen PJ | 0.506952 |
| City Anti-IgE Therapy | 0.499916 |
| asthma | 0.9777 |
| Pongracic JA | 0.498 |
| Szefler SJ | 0.504609 |
| Busse WW. Management | 0.518055 |
| Asthma Control Evaluation | 0.678562 |
| asthma treatment guidelines | 0.681693 |
| Gruchalla RS | 0.496061 |
| Allergy Clin Immunol. | 0.483813 |
| Busse WW. | 0.518705 |
| asthma management | 0.634222 |
| omalizumab | 0.464849 |
| severe allergic asthma | 0.661933 |
|
| asthma morbidity | 0.639521 |
| ICAC investigators | 0.510592 |
| CA. Randomized trial | 0.488723 |
| guidelines-based asthma therapy | 0.667931 |
| asthma presents | 0.660928 |
| nitric oxide level | 0.504737 |
| William Busse | 0.501488 |
| follow-on clinical trial | 0.490114 |
| asthma treatment | 0.724256 |
| public health burden | 0.502806 |
| exhaled nitric oxide | 0.589522 |
| at-risk children | 0.467554 |
| inner city | 0.546793 |
| Liu AH | 0.496615 |
| Teach SJ | 0.501285 |
| clinical guidelines | 0.486081 |
| principal investigators | 0.485986 |
| Asthma counselors | 0.64051 |
| ICAC program | 0.497263 |
| inner-city asthma research | 0.793594 |
| basic research sites | 0.543997 |
| year-long study | 0.459719 |
| inner-city children | 0.771731 |
| asthma symptoms | 0.641572 |
|
CLICK HERE |
| 15541 |
National Institute of Allergy and Infectious Diseases |
Html |
en |
Sample Applications and Summary Statements -- NIAID Research Funding |
Sample Applications and Summary Statements and a list of all samples and examples that are part of the grant application from NIAID and NIH -- NIAID Research Funding |
| application format | 0.907608 |
| grantee organization | 0.765229 |
| funding opportunity | 0.767168 |
| Dr. Andrew Hemmert | 0.871038 |
| new research projects | 0.933476 |
| feasibility studies | 0.741985 |
| R33 phase | 0.759832 |
| ethnic groups | 0.738984 |
| sound examples | 0.760636 |
| sample applications | 0.791811 |
| widely anticipated resource | 0.905833 |
| research community | 0.804124 |
| major recipients | 0.749258 |
| independent research career | 0.905416 |
| small-scale research projects | 0.918897 |
| predoctoral students | 0.755344 |
| good grantsmanship | 0.776715 |
| limited resources | 0.753355 |
| Research Enhancement Award | 0.912673 |
| grant renewal | 0.750527 |
| model systems | 0.747297 |
| R21 phase | 0.802738 |
| original grant application. | 0.876558 |
| exceptional applications | 0.795607 |
|
| two-phased award | 0.744601 |
| latest application format | 0.89336 |
| summary statements | 0.774822 |
| possible transition | 0.745699 |
| new samples | 0.775894 |
| milestone-driven exploratory | 0.747537 |
| new investigators | 0.919996 |
| domestic small businesses | 0.862103 |
| research training | 0.778846 |
| NIH example forms | 0.929049 |
| Dr. Hemmert | 0.748615 |
| nonprofit educational purposes | 0.880734 |
| short period | 0.753535 |
| Small Business Programs | 0.860069 |
| R21 funds novel | 0.915071 |
| research environment | 0.789167 |
| NIH support | 0.763875 |
| disadvantaged backgrounds | 0.737728 |
| *Dr. Mark Poritz | 0.868098 |
| biomedical research | 0.780582 |
| Dr. Poritz | 0.748763 |
| educational institutions | 0.749988 |
| program supports | 0.759468 |
| scientific ideas | 0.747402 |
|
CLICK HERE |
| 15544 |
National Institute of Allergy and Infectious Diseases |
Html |
en |
Global Research in Cambodia |
NIAID-funded research in Cambodia focuses on HIV/AIDS, tuberculosis, malaria, and avian influenza. |
| reports | 0.235345 |
| avian influenza | 0.914596 |
| Cambodia | 0.841837 |
| Khmer population | 0.414517 |
| infectious diseases | 0.430183 |
| Cambodian center | 0.395105 |
| steady growth | 0.450129 |
| malaria-affected areas | 0.409225 |
| malaria research laboratory | 0.84082 |
| malaria drug resistance | 0.823015 |
| malaria treatment | 0.708295 |
| problem | 0.265615 |
| different settings | 0.392781 |
| micronutrients | 0.250825 |
| majority | 0.237584 |
| clinical study | 0.394312 |
| National Center | 0.391275 |
| NIAID-funded research | 0.424039 |
| Parasitology | 0.239748 |
| World Health Organization | 0.596215 |
| avian influenza infection | 0.641213 |
| Intramural Research | 0.416096 |
| clinical research studies | 0.584188 |
| NIAID DIR | 0.565328 |
|
| dengue fever | 0.447449 |
| malaria episode | 0.708655 |
| substandard antimalarial drugs | 0.668757 |
| future collaborative research | 0.563796 |
| natural protection | 0.406267 |
| multidrug resistance | 0.442439 |
| risk behavior | 0.399297 |
| CNM | 0.308846 |
| Phnom Penh | 0.425895 |
| Malaria Control | 0.663084 |
| healthcare | 0.237926 |
| research partnership | 0.40453 |
| counterfeit | 0.247239 |
| particular group | 0.407261 |
| HIV/AIDS | 0.343462 |
| Vector Research | 0.402611 |
| co-infection | 0.260805 |
| NIAID Division | 0.518719 |
| people | 0.265199 |
| malaria deaths | 0.695752 |
| Plasmodium falciparum parasite | 0.624047 |
| antiretroviral therapy | 0.419276 |
| treatment response | 0.400285 |
| education systems | 0.432324 |
|
CLICK HERE |
| 15548 |
National Institute of Allergy and Infectious Diseases |
Html |
en |
Tuberculosis TB, NIAID, NIH |
NIAID is examining TB at its fundamental levels through research to develop faster diagnosis, better vaccines, and shorter treatment times. |
| animal models | 0.484339 |
| treatment strategies | 0.479645 |
| new TB drug | 0.750789 |
| drug-resistant strains | 0.584127 |
| multidrug-resistant TB | 0.705257 |
| optimal drug combinations | 0.547291 |
| TB disease | 0.789313 |
| research findings | 0.480296 |
| severe airborne disease | 0.575915 |
| research | 0.505253 |
| new candidate drugs | 0.571748 |
| death worldwide | 0.485014 |
| novel TB drugs | 0.766874 |
| national history | 0.484991 |
| candidate drugs | 0.572469 |
| active TB disease | 0.746928 |
| TB deaths | 0.714042 |
| major causes | 0.487119 |
| MedlinePlus tuberculosis site | 0.583865 |
| genetic drug | 0.486206 |
| comprehensive portfolio | 0.485226 |
| TB bacterium | 0.688383 |
| latent infections | 0.478461 |
| middle-income countries | 0.49248 |
|
| risk factors | 0.478783 |
| World Health Organization | 0.559465 |
| research infrastructure | 0.479568 |
| early TB disease | 0.745692 |
| NIAID | 0.606471 |
| diagnostic potential | 0.480354 |
| people | 0.530993 |
| TB | 0.982786 |
| biomedical research | 0.486422 |
| new TB drugs | 0.754513 |
| HIV deaths | 0.484548 |
| Mycobacterium tuberculosis | 0.614224 |
| private industry | 0.478347 |
| public health practices | 0.540649 |
| TB diagnosis | 0.691172 |
| clinical studies | 0.55766 |
| prevention strategies | 0.478336 |
| NIAID priority | 0.54559 |
| vaccine clinical trials | 0.538763 |
| Mtb | 0.530457 |
| drug resistance | 0.554266 |
| causative agent | 0.484545 |
| basic research | 0.485797 |
|
CLICK HERE |
| 15549 |
National Institute of Allergy and Infectious Diseases |
Html |
en |
Antimicrobial Drug Resistance, NIAID, NIH |
NIAID supports and conducts research on many aspects of antimicrobial (drug) resistance, or antibiotic resistance, from basic research to clinical trials. |
| new vaccines | 0.274623 |
| infectious diseases | 0.279195 |
| antimicrobial drug treatment | 0.492562 |
| drug-resistant microbes | 0.325369 |
| antimicrobial resistance | 0.928016 |
| infectious organisms | 0.275735 |
| research portfolio | 0.351624 |
| supports research | 0.304893 |
| clinical trials | 0.277383 |
| antimicrobial drug | 0.516315 |
| NIAID laboratories | 0.477113 |
| NIAID-supported research | 0.295594 |
| clinical research | 0.369869 |
| important clinical questions | 0.324644 |
| open NIAID Requests | 0.530136 |
| NIAID Funding Opportunities | 0.523623 |
| NIAID research | 0.580865 |
| hospital-acquired infections | 0.274304 |
| Clinical research projects | 0.349601 |
| drug-resistant Staphylococcus aureus | 0.333068 |
| NIAID conducts | 0.508062 |
| faster diagnostics | 0.275989 |
| Institute’s research | 0.298397 |
| resistant diseases NIAID | 0.561618 |
|
| NIAID researchers | 0.477146 |
| novel prevention strategies | 0.319996 |
| antimicrobial drugs | 0.69881 |
| NIAID research efforts | 0.571105 |
| new antimicrobial therapeutics | 0.459619 |
| public health threats | 0.318497 |
| NIAID’s Antibacterial | 0.53608 |
| Antibacterial Research Program | 0.46669 |
| basic research discoveries | 0.353884 |
| NIAID plans | 0.499656 |
| public health | 0.32965 |
| clinical research activities | 0.348221 |
| antibacterial resistance | 0.553694 |
| NIAID | 0.879483 |
| latest scientific advances | 0.326471 |
| biomedical research | 0.290746 |
| microbes | 0.351855 |
| public health efforts | 0.319101 |
| Research Program accomplishments | 0.354154 |
| antimicrobial resistance research | 0.617628 |
| NIAID efforts | 0.478833 |
| Antibacterial Resistance Leadership | 0.484882 |
| basic research | 0.461234 |
| drug resistant diseases | 0.437539 |
|
CLICK HERE |
| 15980 |
National Institute of Allergy and Infectious Diseases |
Video |
en |
Understanding Food Allergy |
The National Institute of Allergy and Infectious Diseases explains food allergy and offers tips on how to manage the condition. |
| TEDx Talks | 0.301209 |
| Food Allergy Enigma | 0.427335 |
| WARNING Signs | 0.307007 |
| Allergy Skin Tests | 0.422724 |
| ABS-CBN News | 0.319963 |
| Food Allergies | 0.800849 |
| Steve Paikin | 0.306473 |
| tips | 0.220462 |
| Untreated allergic reactions | 0.428934 |
| Mo10ta | 0.219842 |
| Anaphylaxis-Mayo Clinic | 0.294736 |
| Severe Food Allergies | 0.523532 |
| Sonia Hunt | 0.304266 |
| Duration | 0.977395 |
| Good Morning | 0.305532 |
| Dr. John Bergman | 0.374323 |
| eMedTV | 0.221562 |
| Stay Safe | 0.301006 |
| symptoms | 0.217567 |
| condition | 0.220423 |
| Infectious Diseases | 0.318448 |
| Foods | 0.218524 |
| Food Allergens | 0.31897 |
| Live Healthy | 0.301596 |
| Gluten Intolerance | 0.31617 |
|
| Mayo Clinic | 0.294446 |
| Cure Allergies FAST | 0.483591 |
| Signature Medical Group | 0.391029 |
| Food Intolerances | 0.341701 |
| boy | 0.235485 |
| Allergies Are Tired | 0.41865 |
| ABC News | 0.406616 |
| America | 0.2185 |
| Food Can Kill | 0.320007 |
| Severe Food Allergy | 0.452133 |
| views | 0.647848 |
| National Institute | 0.318188 |
| Immune Response | 0.297675 |
| Sensitivities | 0.221006 |
| Agenda | 0.21749 |
| NIAID | 0.224612 |
| food allergy | 0.513642 |
| Food Control Plan | 0.393618 |
| TEDxUCDavisSF | 0.217779 |
| Fatal Allergies | 0.417301 |
| National Geographic | 0.373164 |
| Rita Mustafa | 0.302426 |
| PsycheTruth | 0.219651 |
| Ana Pena | 0.303769 |
|
CLICK HERE |
| 15981 |
National Institute of Allergy and Infectious Diseases |
Video |
en |
Influenza: Get the (Antigenic) Drift |
Have you ever wondered why you need a flu vaccination each year? The National Institute of Allergy and Infectious Diseases explains the ever-changing nature of influenza viruses. |
| Action MOA Animation | 0.579913 |
| Shomu | 0.416725 |
| Allergy | 0.416577 |
| SwineFlu | 0.416001 |
| Daniel Levy | 0.496516 |
| flutube100 | 0.416238 |
| Osmosis | 0.416074 |
| H1N1 Swine Flu | 0.627108 |
| Unpredictable Threat | 0.498722 |
| flu vaccination | 0.597572 |
| milos velja | 0.493184 |
| World Health Organization | 0.57148 |
| 1918 Flu Pandemic | 0.627835 |
| flu virus mechanism | 0.693678 |
| reverse transcriptase | 0.494547 |
| Duration | 0.949875 |
| Virus Invades | 0.512664 |
| AMAZING DOCUMENTARY | 0.485888 |
| autoplay | 0.453443 |
| HIV life cycle | 0.567135 |
| Carolyn Bertozzi | 0.598025 |
| Infectious Diseases | 0.507143 |
| Influenza H1N1 Mechanism | 0.7022 |
| VIRUS EVOLUTION | 0.501245 |
| antigenic shift | 0.607123 |
|
| influenza | 0.762967 |
| 720p | 0.423131 |
| iBioEducation | 0.42898 |
| Influenza animation | 0.642901 |
| Influenza Pandemics Occur | 0.718554 |
| Biology | 0.416713 |
| video | 0.418444 |
| Genetic Shift | 0.503494 |
| Berkeley/HHMI | 0.429072 |
| ever-changing nature | 0.51424 |
| views | 0.737316 |
| National Institute | 0.509002 |
| Fighting flu | 0.555906 |
| Influenza infection model | 0.670194 |
| Immune Response | 0.487687 |
| David Hager | 0.509045 |
| Scientific Animations | 0.498803 |
| DOCUMENTARY TUBE | 0.482643 |
| NIAID | 0.456714 |
| Influenza Virus Infection | 0.688245 |
| Flu Attack | 0.564409 |
| influenza viruses | 0.646604 |
| Nucleus Medical Media | 0.585917 |
| Million People | 0.484786 |
|
CLICK HERE |